Telemedicine in Covid-19: Challenges and Opportunities

Main Article Content

Imrana Masood
Ummul Baneen
. Nivedita

Abstract

The pandemic of COVID -19 is a healthcare emergency of International concern. It originated in Wuhan, China in December 2019 and was declared as pandemic by WHO on 12 March 2020. Since then it is raging relentlessly across the world with staggering more than 60 lakh cases in India currently. This has put a tremendous strain on already frail and overburdened Indian healthcare system and aggravated concern in the accessibility to healthcare by common mass due to prevailing lockdown conditions. This has sparkled to re-think and renew the policy on healthcare and focus on relevance, reach and utilize the potential of telemedicine services for the delivery of healthcare to community. This term telemedicine has been in use since 1970s but became fully operational globally in early 2000. Now about 20 years later we find a revolutionary change in the focus of health services delivery towards community healthcare and wellbeing In this article we aim to analyze the difficulties and hurdles faced by non COVID patients and challenges in front of the government to dispense basic healthcare to those in need. We need to tap all our resources particularly ICT for healthcare delivery and use this adversity of COVID 19 pandemic as an opportunity to build on our capacity and expertise in the area of Telemedicine for the betterment of community healthcare.

Keywords:
Telemedicine, COVID-19 pandemic

Article Details

How to Cite
Masood, I., Baneen, U., & Nivedita, . (2021). Telemedicine in Covid-19: Challenges and Opportunities. Asian Journal of Research in Medical and Pharmaceutical Sciences, 10(2), 32-35. https://doi.org/10.9734/ajrimps/2021/v10i230160
Section
Short Communication

References

WHO Novel coronavirus (2019-nCoV) situation reports; 2019.
Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/ situation-reports
Accessed: 2020 April 2.

Rockwell KL, Gilroy AS. Incorporating telemedicine as part of COVID-19 outbreak response systems. Am J Manag Care. 2020;26:147-8.

WHO. Strengthening the health system response to COVID-19 Recommendations for the WHO European Region Policy brief. Geneva: World Health Organization; 2020.
Available:http://www.euro.who.int/__data/assets/pdf_file/0003/436350/strengthening-health-system-response-COVID-19.pdf.
Accessed: 28 Apr 2020.

Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020.

Hollander JE, Carr BG. Telemedicine for Covid-19 virtually perfect? Engl J Med. 2020;382(18)

Lamontagne F, Agoritsas T, Macdonald H, et al. A living WHO guideline on drugs for COVID-19. BMJ. 2020;370:m3379

Kasaragod borders can't be opened, says K'taka: Court seeks a humane solution. The news minute [Internet]; 2020.
[cited 2020 April 28].
Available:https://www.thenewsminute.com/article/kasaragod- borders-can-t-be-opened-says-k- takacourt-seeks-humane-solution-121549.

Harst L, Lantzsch H, Scheibe M. Theories predicting end-user acceptance of telemedicine use: Systematic review. J Med Internet Res. 2019;21:e13117.

Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anaesth. 2020;67.

Sudhamony S, Nandakumar K, Binu P, Niwas SI. Telemedicine and tele-health services for cancer-care delivery in India. IET Commun. 2008;2:231-6.